New generic blood thinner put to the test in healthy volunteers
NCT ID NCT07517289
First seen May 02, 2026 · Last updated May 16, 2026 · Updated 2 times
Summary
This early-stage study checks if a new generic version of the blood thinner enoxaparin works the same as the brand-name drug Clexane. About 26 healthy adults will receive a single dose of each drug, one week apart, and have their blood tested. The goal is to see if the generic is a safe and effective alternative.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS STUDY are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.